Selected research
Industry Research
Phenprocoumon Industry Research Report 2026
Market perspective
The global Phenprocoumon market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Phenprocoumon is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Phenprocoumon is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Phenprocoumon include Teva, Novartis, Mylan, Roche, Wörwag Pharma, Divis Labs, Aspen Pharmacare and Acis Arzneimittel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Phenprocoumon market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Phenprocoumon Market by Company
Teva
Novartis
Mylan
Roche
Wörwag Pharma
Divis Labs
Aspen Pharmacare
Acis Arzneimittel
Phenprocoumon Segment by Type
5 mg
10 mg
25 mg
50 mg
Phenprocoumon Segment by Application
Pulmonary Embolism
Venous Thrombosis
Thromboembolism
Others
Phenprocoumon Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenprocoumon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phenprocoumon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenprocoumon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Phenprocoumon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Phenprocoumon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Phenprocoumon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5 mg
- 10 mg
- 25 mg
- 50 mg
Applications
- Pulmonary Embolism
- Venous Thrombosis
- Thromboembolism
- Others
Companies covered
- Teva
- Novartis
- Mylan
- Roche
- Wörwag Pharma
- Divis Labs
- Aspen Pharmacare
- Acis Arzneimittel
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Phenprocoumon Market Size (2021-2032)
- 2.2.2 Global Phenprocoumon Sales (2021-2032)
- 2.2.3 Global Phenprocoumon Market Average Price (2021-2032)
- 2.3 Phenprocoumon by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5 mg
- 2.3.3 10 mg
- 2.3.4 25 mg
- 2.3.5 50 mg
- 2.4 Phenprocoumon by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pulmonary Embolism
- 2.4.3 Venous Thrombosis
- 2.4.4 Thromboembolism
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Phenprocoumon Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Phenprocoumon Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Phenprocoumon Revenue of Manufacturers (2021-2026)
- 3.4 Global Phenprocoumon Average Price by Manufacturers (2021-2026)
- 3.5 Global Phenprocoumon Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Phenprocoumon, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Phenprocoumon, Product Type & Application
- 3.8 Global Manufacturers of Phenprocoumon, Established Date
- 3.9 Global Phenprocoumon Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Phenprocoumon Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Phenprocoumon Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Phenprocoumon Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Roche
- 4.4.1 Roche Company Information
- 4.4.2 Roche Business Overview
- 4.4.3 Roche Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Phenprocoumon Product Portfolio
- 4.4.5 Roche Recent Developments
- 4.5 Wörwag Pharma
- 4.5.1 Wörwag Pharma Company Information
- 4.5.2 Wörwag Pharma Business Overview
- 4.5.3 Wörwag Pharma Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wörwag Pharma Phenprocoumon Product Portfolio
- 4.5.5 Wörwag Pharma Recent Developments
- 4.6 Divis Labs
- 4.6.1 Divis Labs Company Information
- 4.6.2 Divis Labs Business Overview
- 4.6.3 Divis Labs Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Divis Labs Phenprocoumon Product Portfolio
- 4.6.5 Divis Labs Recent Developments
- 4.7 Aspen Pharmacare
- 4.7.1 Aspen Pharmacare Company Information
- 4.7.2 Aspen Pharmacare Business Overview
- 4.7.3 Aspen Pharmacare Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Aspen Pharmacare Phenprocoumon Product Portfolio
- 4.7.5 Aspen Pharmacare Recent Developments
- 4.8 Acis Arzneimittel
- 4.8.1 Acis Arzneimittel Company Information
- 4.8.2 Acis Arzneimittel Business Overview
- 4.8.3 Acis Arzneimittel Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Acis Arzneimittel Phenprocoumon Product Portfolio
- 4.8.5 Acis Arzneimittel Recent Developments
5 Global Phenprocoumon Market Scenario by Region
- 5.1 Global Phenprocoumon Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Phenprocoumon Sales by Region: 2021-2032
- 5.2.1 Global Phenprocoumon Sales by Region: 2021-2026
- 5.2.2 Global Phenprocoumon Sales by Region: 2027-2032
- 5.3 Global Phenprocoumon Revenue by Region: 2021-2032
- 5.3.1 Global Phenprocoumon Revenue by Region: 2021-2026
- 5.3.2 Global Phenprocoumon Revenue by Region: 2027-2032
- 5.4 North America Phenprocoumon Market Facts & Figures by Country
- 5.4.1 North America Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Phenprocoumon Sales by Country (2021-2032)
- 5.4.3 North America Phenprocoumon Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Phenprocoumon Market Facts & Figures by Country
- 5.5.1 Europe Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Phenprocoumon Sales by Country (2021-2032)
- 5.5.3 Europe Phenprocoumon Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Phenprocoumon Market Facts & Figures by Country
- 5.6.1 Asia Pacific Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Phenprocoumon Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Phenprocoumon Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Phenprocoumon Market Facts & Figures by Country
- 5.7.1 South America Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Phenprocoumon Sales by Country (2021-2032)
- 5.7.3 South America Phenprocoumon Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Phenprocoumon Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Phenprocoumon Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Phenprocoumon Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Phenprocoumon Sales by Type (2021-2032)
- 6.1.1 Global Phenprocoumon Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Phenprocoumon Sales Market Share by Type (2021-2032)
- 6.2 Global Phenprocoumon Revenue by Type (2021-2032)
- 6.2.1 Global Phenprocoumon Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Phenprocoumon Revenue Market Share by Type (2021-2032)
- 6.3 Global Phenprocoumon Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Phenprocoumon Sales by Application (2021-2032)
- 7.1.1 Global Phenprocoumon Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Phenprocoumon Sales Market Share by Application (2021-2032)
- 7.2 Global Phenprocoumon Revenue by Application (2021-2032)
- 7.2.1 Global Phenprocoumon Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Phenprocoumon Revenue Market Share by Application (2021-2032)
- 7.3 Global Phenprocoumon Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Phenprocoumon Value Chain Analysis
- 8.1.1 Phenprocoumon Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Phenprocoumon Production Mode & Process
- 8.2 Phenprocoumon Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Phenprocoumon Distributors
- 8.2.3 Phenprocoumon Customers
9 Global Phenprocoumon Analyzing Market Dynamics
- 9.1 Phenprocoumon Industry Trends
- 9.2 Phenprocoumon Industry Drivers
- 9.3 Phenprocoumon Industry Opportunities and Challenges
- 9.4 Phenprocoumon Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst